DocDollars

Pentax of America, Inc.

NJ · United States · Reporting entity ID 100000000259

Total reported 2019–2025
$6.07M
#644 of 2,960 reporting companies — 0% of all reported industry payments
$2.31M in general payments across 3,540 records, plus $3.76M in research funding across 225 records.

How it breaks down

General payments $2,309,226
Research funding $3,761,105

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Pentax of America, Inc. reported $6.07M to US doctors and teaching hospitals from 2019 to 2025, ranking #644 of 2,960 reporting companies. 62% of that was research funding and 38% general payments such as consulting, speaking, food and travel. 3,540 general payment records and 225 research records were filed.

Common questions about Pentax of America, Inc.

How much has Pentax of America, Inc. paid US doctors?

Pentax of America, Inc. reported $6,070,331 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $2,309,226 in general payments, $3,761,105 in research funding.

How does Pentax of America, Inc. rank among drug and device companies?

It ranks #644 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Pentax of America, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.